Overview

Effect of Antenatal Corticosteroids in Late Preterm

Status:
Unknown status
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
To test the effect on premature infants of a one-time course of betamethasone administered in weeks 34-36 of gestation.
Phase:
Phase 2
Details
Lead Sponsor:
Meir Medical Center
Treatments:
Betamethasone
Betamethasone benzoate
Betamethasone sodium phosphate
Betamethasone Valerate
Betamethasone-17,21-dipropionate